These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 580690)

  • 1. [Pharmacological and therapeutic effects of nicotinic acid unrelated to the vitamin activity].
    Condorelli L
    Acta Vitaminol Enzymol; 1977; 31(1-5):57-84. PubMed ID: 580690
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pharmacologic properties and indications of modern vasodilator agents. 2: Indications and side effects of vasodilator agents].
    Langnickel R; Bluth R
    Z Arztl Fortbild (Jena); 1985; 79(20):867-73. PubMed ID: 3936287
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pharmacodynamic study of stenocardia of effort. 3. Effect of nicotinic acid].
    Sangiorgi M; Moscatello B; Malarbi A; Pierangeli L; Mastroberardino G; Cannata D
    Boll Soc Ital Cardiol; 1970; 15(3):226-47. PubMed ID: 5475740
    [No Abstract]   [Full Text] [Related]  

  • 4. Adrenergic theory: application to clinical and experimental surgery.
    Reynolds DG; Turtinen LW; Kerr JC; Swan KG
    Am Surg; 1975 Apr; 41(4):185-8. PubMed ID: 47731
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effects of the nicotinic ester of 7(2-hydroxyethyl)-theophylline on peripheral arteriopathies in the aged].
    Bandinelli G; De Mauro G; Provvedi D; Bellini PG; Rubegni M
    Cardiol Prat; 1973; 24(3):275-80. PubMed ID: 4779825
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of an inosite-nicotinic acid-ester on serum lipid changes in patients with vascular diseases].
    Hammerl H; Kränzl C; Pichler ; Studlar M
    Munch Med Wochenschr; 1969 Sep; 111(38):1912-6. PubMed ID: 5394857
    [No Abstract]   [Full Text] [Related]  

  • 7. [Activation of fibrinolysis after oral administration of D-glucitol-hexanicotinate. Preliminary data].
    Pinto A; Novo S; Avellone G; Vinci G
    Boll Soc Ital Cardiol; 1978; 23(4):641-5. PubMed ID: 757348
    [No Abstract]   [Full Text] [Related]  

  • 8. Positive and negative outcomes of L-arginine therapy in cardiovascular diseases.
    Herbaczyńska-Cedro K
    J Physiol Pharmacol; 1999 Dec; 50(4):653-60. PubMed ID: 10639015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Role of calcium antagonists in the treatment of cardiovascular diseases].
    Akhmedkhanov SSh; Pomerantsev VP; Vasiuk IuA; Mdinaradze IuS
    Sov Med; 1985; (3):44-51. PubMed ID: 3895459
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hemokinetic and metabolic action of 7-2-(3-pyridyl-methylamino)-ethyl-theophylline nicotinate as a basis of medical treatment of chronic obliterating peripheral arteriopathy].
    Cascio F
    Minerva Cardioangiol; 1973 Nov; 21(11):715-31. PubMed ID: 4776567
    [No Abstract]   [Full Text] [Related]  

  • 11. Hyperlipidaemia and cardiovascular disease: nonantilipolytic effects of nicotinic acid in adipose tissue.
    Karpe F; Chamas L
    Curr Opin Lipidol; 2010 Jun; 21(3):282-3. PubMed ID: 20463475
    [No Abstract]   [Full Text] [Related]  

  • 12. [Dopaminergic stimulation in cardiology: its current status and future strategies].
    Cherchi A; Mercuro G
    Cardiologia; 1987 Dec; 32(12):1631-9. PubMed ID: 3329022
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pharmacological action of coffee].
    Gambigliani Zoccoli A
    Minerva Med; 1971 Aug; 62(64):3013-6. PubMed ID: 5566883
    [No Abstract]   [Full Text] [Related]  

  • 14. [Vasodilation caused by inhibition of calcium ions as a factor of increasing oxygen transport in peripheral vascular diseases].
    Pola P; Savi L; Dal Lago A; Zucchiatti V
    Clin Ter; 1977 Jun; 81(5):417-31. PubMed ID: 884936
    [No Abstract]   [Full Text] [Related]  

  • 15. [On the effects of cardiokinetic drugs on latent cardiocirculatory insufficiency of the senile heart].
    Martelli A; Malaguti P; Casoni I
    Acta Gerontol (Milano); 1970; 20(4):247-55. PubMed ID: 5514133
    [No Abstract]   [Full Text] [Related]  

  • 16. Cardiovascular effects of peridural block.
    Bonica JJ
    Clin Anesth; 1969; 2():63-81. PubMed ID: 4932640
    [No Abstract]   [Full Text] [Related]  

  • 17. Nicotinic acid in the treatment of lipid disorders.
    Labreche DG
    Pharmacotherapy; 1989; 9(4):270-1. PubMed ID: 2671960
    [No Abstract]   [Full Text] [Related]  

  • 18. [Behavior of renal clearances in the phase of the vasomotor effect of nicotinic acid].
    Armellini C; Consolo F
    Boll Soc Ital Biol Sper; 1967 Jul; 43(13):752-5. PubMed ID: 6055230
    [No Abstract]   [Full Text] [Related]  

  • 19. [Problem of vasodilatation in the therapy of arterial diseases].
    Pratesi F; Caramelli L; Corsi C; Spinelli P; Tesi M
    Minerva Cardioangiol; 1973 Mar; 21(3):197-211. PubMed ID: 4708941
    [No Abstract]   [Full Text] [Related]  

  • 20. [Nicotinic acid in the treatment of chronic circulatory failure in patients with ischemic heart disease].
    Kats GL; Zhivotovskaia IA; Gnilitskaia VB; Alifanova RE; Mal'tseva NV
    Vrach Delo; 1989 Sep; (9):16-9. PubMed ID: 2609611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.